Search

Your search keyword '"Zambrano, Melba"' showing total 2 results
Start Over Author "Zambrano, Melba" Topic pseudomonas aeruginosa
2 results on '"Zambrano, Melba"'

1. Notes from the Field: Verona Integron-Encoded Metallo-β-Lactamase-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections in U.S. Residents Associated with Invasive Medical Procedures in Mexico, 2015-2018.

Author

Kracalik I, Ham C, Smith AR, Vowles M, Kauber K, Zambrano M, Rodriguez G, Garner K, Chorbi K, Cassidy PM, McBee S, Stoney R, Brown AC, Moser K, Villarino ME, and Walters MS

Subjects
Adult, Female, Humans, Male, Mexico, Middle Aged, United States epidemiology, Carbapenems pharmacology, Integrons, Medical Tourism, Pseudomonas Infections epidemiology, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa isolation & purification, beta-Lactamases biosynthesis
Abstract

Competing Interests: All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Published
2019
Full Text
View/download PDF

2. Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019.

Author

Kracalik, Ian, Ham, D. Cal, McAllister, Gillian, Smith, Amanda R., Vowles, Maureen, Kauber, Kelly, Zambrano, Melba, Rodriguez, Gretchen, Garner, Kelley, Chorbi, Kaitlyn, Cassidy, P. Maureen, McBee, Shannon, Stoney, Rhett J., Moser, Kathleen, Villarino, Margarita E., Zazueta, Oscar E., Bhatnagar, Amelia, Sula, Erisa, Stanton, Richard A., and Brown, Allison C.

Subjects
MEDICAL tourism, PSEUDOMONAS aeruginosa, CARBAPENEM-resistant bacteria, NUCLEOTIDE sequencing, BARIATRIC surgery
Abstract

Carbapenem-resistant Pseudomonas aeruginosa (CRPA) producing the Verona integron‒encoded metallo-β-lactamase (VIM) are highly antimicrobial drug-resistant pathogens that are uncommon in the United States. We investigated the source of VIM-CRPA among US medical tourists who underwent bariatric surgery in Tijuana, Mexico. Cases were defined as isolation of VIM-CRPA or CRPA from a patient who had an elective invasive medical procedure in Mexico during January 2018‒December 2019 and within 45 days before specimen collection. Whole-genome sequencing of isolates was performed. Thirty-eight case-patients were identified in 18 states; 31 were operated on by surgeon 1, most frequently at facility A (27/31 patients). Whole-genome sequencing identified isolates linked to surgeon 1 were closely related and distinct from isolates linked to other surgeons in Tijuana. Facility A closed in March 2019. US patients and providers should acknowledge the risk for colonization or infection after medical tourism with highly drug-resistant pathogens uncommon in the United States. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results